Field effectiveness of erythromycin prophylaxis to prevent pertussis within families

Pediatr Infect Dis J. 1995 Nov;14(11):969-75. doi: 10.1097/00006454-199511000-00009.

Abstract

To evaluate the field effectiveness of erythromycin prophylaxis for pertussis within families, a retrospective cohort study was conducted among 246 families. Overall 41% of the subjects (387 of 940) had been sick. The secondary attack rate was 65% for infants younger than 2 years, 54% for those 2 to 4 years old and 39% for children 5 to 9 years old, and it declined thereafter. The secondary attack rate decreased from 25% in families without prophylaxis to 17% in families with prophylaxis. The protection induced by prophylaxis did not vary with age or vaccination status. When prophylaxis was used before the onset of a secondary case, the secondary attack rate was 4% compared with 35% when given after a secondary case (P < 0.001). Erythromycin prophylaxis seems to be efficient in preventing secondary cases but is most useful when administered before the occurrence of the first secondary case.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Age Distribution
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use*
  • Child
  • Child, Preschool
  • Cohort Studies
  • Disease Transmission, Infectious / prevention & control*
  • Erythromycin / administration & dosage
  • Erythromycin / therapeutic use*
  • Evaluation Studies as Topic
  • Family
  • Humans
  • Infant
  • Logistic Models
  • Multivariate Analysis
  • Retrospective Studies
  • Treatment Outcome
  • Whooping Cough / drug therapy
  • Whooping Cough / prevention & control*
  • Whooping Cough / transmission

Substances

  • Anti-Bacterial Agents
  • Erythromycin